Quick Takeaways
- Oaktree Capital Group Holdings GP, LLC filed SCHEDULE 13G/A for ADC Therapeutics SA Common Shares (ADCT).
- Disclosed ownership: 4.1%.
- Date of event: 30 Sep 2025.
Oaktree Capital Group Holdings GP, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for ADC Therapeutics SA Common Shares (ADCT)
- Filing Manager
- Oaktree Capital Group Holdings GP, LLC
- Reporting Manager
- Oaktree Fund Administration, LLC
- Security
- ADC Therapeutics SA Common Shares
- Symbol
- ADCT
- Shares outstanding
- 112,885,048 shares
- Disclosed Ownership
- 4,673,441 shares
- Ownership
- 4.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 Nov 2025, 16:05:19 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Oaktree Capital Group Holdings GP, LLC disclosed 4.1% ownership in ADC Therapeutics SA Common Shares (ADCT) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Nov 2025, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (7)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Oaktree Fund Administration, LLC | 4.1% | 4,673,441 | 0 | 4,673,441 | /s/ Henry Orren | Henry Orren/ Senior Vice President | |
| Oaktree Capital Holdings, LLC | 4.1% | 4,673,441 | 0 | 4,673,441 | /s/ Henry Orren | Henry Orren/ Senior Vice President | |
| Oaktree Capital Group Holdings GP, LLC | 4.1% | 4,673,441 | 0 | 4,673,441 | /s/ Henry Orren | Henry Orren/ Senior Vice President | |
| Brookfield Asset Management ULC | 0% | 0 | 0 | 0 | /s/ Kathy Sarpash | Kathy Sarpash/Managing Director, Legal & Regulatory | |
| Brookfield Corporation | 0% | 0 | 0 | 0 | /s/ Swati Mandava | Swati Mandava/ Managing Director, Legal & Regulatory | |
| Brookfield Asset Management, Ltd. | 0% | 0 | 0 | 0 | /s/ Kathy Sarpash | Kathy Sarpash/ Managing Director, Legal & Regulatory | |
| BAM Partners Trust | 0% | 0 | 0 | 0 | /s/ Kathy Sarpash | Kathy Sarpash/Secretary |